SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories - Quaterly Results

14 Aug 2024 Evaluate
An increase of about 133.68% to Rs. 316.56 millions in the total revenue was observed for the quarter ended June 2024. The total revenue was pegged at Rs. 135.47 millions during the similar quarter previous year.The Net Profit of the company reported a remarkable increase of 378.01% to Rs. 88.05  millions  from Rs. 18.42 millions in previous same quarter.Operating Profit saw a handsome growth to 122.97 millions from 30.32 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 316.56 135.47 133.68 316.56 135.47 133.68 836.60 781.18 7.09
Other Income 15.61 12.91 20.91 15.61 12.91 20.91 66.32 68.95 -3.81
PBIDT 122.97 30.32 305.57 122.97 30.32 305.57 228.71 107.07 113.61
Interest 0.28 0.00 0.00 0.28 0.00 0.00 0.00 3.38 -100.00
PBDT 122.69 30.32 304.65 122.69 30.32 304.65 227.07 104.07 118.19
Depreciation 4.94 5.45 -9.36 4.94 5.45 -9.36 19.76 21.80 -9.36
PBT 117.75 24.87 373.46 117.75 24.87 373.46 207.31 82.27 151.99
TAX 29.70 6.45 360.47 29.70 6.45 360.47 49.43 17.81 177.54
Deferred Tax 0.20 0.20 0.00 0.20 0.20 0.00 0.34 -0.39 -187.18
PAT 88.05 18.42 378.01 88.05 18.42 378.01 157.88 64.46 144.93
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 38.85 22.38 73.56 38.85 22.38 73.56 27.34 13.71 99.46

Coral Laboratories Share Price

421.20 7.90 (1.91%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×